These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 2675803

  • 21. Crystalline retinopathy: evaluation of blood-retinal barrier by vitreous fluorophotometry.
    Yoshida A, Nara Y, Takahashi M.
    Jpn J Ophthalmol; 1985; 29(3):290-300. PubMed ID: 4079126
    [Abstract] [Full Text] [Related]

  • 22. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC, Chu HH, Garcia CA, Anderson RE, Field JB, Orzeck EA, Comstock JP.
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [Abstract] [Full Text] [Related]

  • 23. Ocular fluorophotometry in diabetic patients without apparent retinopathy.
    Kayazawa F.
    Ann Ophthalmol; 1984 Mar; 16(3):221-5. PubMed ID: 6712065
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Axial and para-axial fluorophotometry in glaucoma simplex.
    Szymanski A, Gierek-Lapinska A, Koziak M, Gierek-Kalicka S.
    Int Ophthalmol; 1992 Sep; 16(4-5):283-5. PubMed ID: 1428558
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R, Ohrloff C.
    Ophthalmic Res; 1995 Sep; 27 Suppl 1():116-23. PubMed ID: 8577448
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG, Brubaker RF.
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [Abstract] [Full Text] [Related]

  • 36. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.
    Kaufmann F, Lacoste C.
    Diabetologia; 1986 Mar; 29(3):175-80. PubMed ID: 3516774
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.